- Home
- ODD vs EOLS Comparison
ODD vs EOLS Comparison
Compare ODD & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ODD | EOLS |
|---|---|---|
| Founded | 2018 | 2012 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 651.3M | 550.9M |
| IPO Year | 2022 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ODD | EOLS |
|---|---|---|
| Price | $13.35 | $8.18 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 5 |
| Target Price | ★ $41.00 | $15.50 |
| AVG Volume (30 Days) | 686.8K | ★ 934.6K |
| Earning Date | 05-12-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1.23 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $297,176,000.00 |
| Revenue This Year | N/A | $13.27 |
| Revenue Next Year | $22.92 | $17.62 |
| P/E Ratio | $16.73 | ★ N/A |
| Revenue Growth | N/A | ★ 11.61 |
| 52 Week Low | $9.25 | $3.86 |
| 52 Week High | $64.23 | $8.43 |
Technical Indicators
Market Signals| Indicator | ODD | EOLS |
|---|---|---|
| Relative Strength Index (RSI) | 42.58 | 71.95 |
| Support Level | $12.53 | $6.44 |
| Resistance Level | $14.61 | N/A |
| Average True Range (ATR) | 0.91 | 0.40 |
| MACD | -0.28 | 0.23 |
| Stochastic Oscillator | 22.77 | 88.38 |
Price Performance
Historical ComparisonAbout ODD ODDITY Tech Ltd.
ODDITY Tech Ltd offers a consumer tech platform that is built to transform the beauty and wellness market. The ODDITY platform is designed to support a portfolio of brands and services that innovate and disrupt the expansive beauty and wellness market. It consumes user data to develop physical beauty and wellness products that deliver performance and functionality. Its brands include SpoiledChild and IL Makiage. Geographically, the company generates majority revenue from United states followed by other countries and Israel.
About EOLS Evolus Inc.
Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.